Advisory Board

Name

Expertise

Education

Major Experiences

Prof. Pei-Jer Chen

Internal Medicine, Gastroenterology, Molecular biology and virology, Cancer genome

Ph.D., University of Pennsylvania, Philadelphia, U.S.A.

  • Academician, Academia Sinica (Taiwan, ROC.)
  • Attending Physician, DEPT. of Gastroenterology and Hepatology, National Taiwan U. Hospital
  • Professor, College of Medicine, National Taiwan U.
  • Outstanding Technological Talent, Executive Yuan, Taiwan, ROC.)
  • Main Principal investigator of BELX’s HBV phase IItrial 

Prof. Po-Huang Lee

Hepatobiliary surgery, Liver Transplantation

Ph.D., Institute of Clinical Medicine National Taiwan University College of Medicine

  • Director, DEPT. of Medicine and Surgery, National Taiwan U. Hospital
  • Professor of Surgery, College of Medicine, National Taiwan U.
  • Member and Vice President, International Society for Digestive Surgery
  • President, Asian Surgical Association

Dr. Shaw T Chen

 

International drug regulation, Clinical trial, Drug safety monitoring

Doctor of Medicine, University of Miami, U.S.A.

Ph.D., Johns Hopkins University, U.S.A

  • Director of Botanical Drugs, U.S. FDA
  • Deputy Director of Audit Department, U.S. FDA
  • Biotechnology Advisory Committee, Executive Yuan, Taiwan
  • Executive Vice President, Polaris Pharma

Chih-Hsien Liu

Clinical trial, Biostatistics,

Business plan

MS, Statistics,

The University of Iowa, U.S.A.

MSCS, Computer Science,

University of Minnesota, U.S.A

  • Chairman, Fidelitas Int’ Corporation
  • Vice president, General manager Asia pacific, PAREXEL International
  • Chairman, Apex Int’ Clinical Research
  • Instructor, Ins. of Clinical Medicine, NYCU

Dr. Lai-Ju Chen

Startup enterprise, 

Marketing

Thunderbird School of Global Management

Ph.D., Chemical Engineering. National Tsing Hua University

  • Manager, ITRI
  • President and CEO of AUO
  • Angel Business Committee ofNational Development Fund, Executive Yuan
  • CEO, Sunnyhills
  • Chairman, Kingyoup Optronics. Co., Ltd.

Dr. Yu-Li Chang

Botanical new drug development & management

Ph.D., University of Pennsylvania, Philadelphia, U.S.A.

  • Program Director, Botanical new drug development program sponsored by DOIT of MOEA, ITRI
  • Division Director, Herbal Medicinal Product Technology Division, ITRI
  • Director, Bulk pharmaceuticals pilot plant, ITRI
  • Co-founder, BELX Bio-pharmaceutical

Wei-Min Chang

Marketing, Pharmaceutical PIC/S GMP manufacturing

M.S.,ChE, Connecticut University, U.S.A.

  • Vice President, Savior Lifetec Co.
  • Vice President of New Drug Operations, WuXi AppTec
  • General Manager, Keystone Pharmaceuticals
  • Manager, Everlight Chemical Co.